2nd Circ. Won't Revive Suit Against Pfizer Over Lipitor
The Second Circuit on Wednesday denied an appeal by patients alleging that Pfizer Inc.'s former cholesterol drug Lipitor gave them Type 2 diabetes, agreeing with the trial court's decision that their...To view the full article, register now.
Already a subscriber? Click here to view full article